Eliem Therapeutics Ownership | Who Owns Eliem Therapeutics?

Eliem Therapeutics Ownership Summary

Eliem Therapeutics is owned by 164.45% institutional investors, 10.38% insiders. Ra capital management is the largest institutional shareholder, holding 103.52% of ELYM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.34% of its assets in Eliem Therapeutics shares.

ELYM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eliem Therapeutics	164.45%	10.38%	-74.83%
Sector	Healthcare Stocks	47.38%	7.99%	44.63%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	31.42M	103.52%	$223.39M
Deep track capital, lp	3.90M	12.87%	$27.76M
Samsara biocapital	3.26M	10.75%	$23.19M
Janus henderson group	3.25M	10.72%	$23.14M
Boxer capital	2.60M	8.58%	$18.51M
Affinity asset advisors	1.67M	5.50%	$11.88M
Driehaus capital management	696.06K	2.29%	$4.95M
Ally bridge group (ny)	500.00K	1.65%	$3.56M
Blackrock	381.72K	1.38%	$2.71M
Vanguard group	326.38K	1.18%	$2.32M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Samsara biocapital	3.26M	4.85%	$23.19M
Ra capital management	31.42M	2.95%	$223.39M
Ally bridge group (ny)	500.00K	2.12%	$3.56M
Affinity asset advisors	1.67M	1.37%	$11.88M
Boxer capital	2.60M	0.97%	$18.51M
Deep track capital, lp	3.90M	0.83%	$27.76M
Sphera funds management	215.18K	0.21%	$1.53M
Adar1 capital management	97.69K	0.13%	$694.61K
Ikarian capital	100.00K	0.12%	$711.00K
Driehaus capital management	696.06K	0.05%	$4.95M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	31.42M	2.95%	18.27M
Deep track capital, lp	3.90M	0.83%	3.90M
Samsara biocapital	3.26M	4.85%	3.26M
Janus henderson group	3.25M	0.01%	3.25M
Boxer capital	2.60M	0.97%	2.60M

Top Sellers

Holder	Shares	% Assets	Change
Bml capital management	-	-	-2.19M
Adage capital partners gp	-	-	-670.36K
Walleye capital	-	-	-196.39K
Driehaus capital management	696.06K	0.05%	-115.62K
Atom investors lp	-	-	-78.28K

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	3.90M	0.83%	3.90M	$27.76M
Samsara biocapital	3.26M	4.85%	3.26M	$23.19M
Janus henderson group	3.25M	0.01%	3.25M	$23.14M
Boxer capital	2.60M	0.97%	2.60M	$18.51M
Affinity asset advisors	1.67M	1.37%	1.67M	$11.88M

Sold Out

Holder	Change
Qube research	-981.00
Two sigma securities	-10.62K
Polar asset management partners	-10.78K
Chicago partners investment group	-12.10K
Woodline partners lp	-22.19K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	47	135.00%	49,910,065	196.11%	164	4.42%	41	583.33%	4	-
Mar 31, 2024	20	-9.09%	16,855,387	0.01%	60	1.56%	6	-14.29%	4	-42.86%
Dec 31, 2023	22	-	16,853,724	0.75%	62	1.64%	7	-12.50%	7	-
Sep 30, 2023	22	4.76%	16,728,590	-0.01%	61	1.59%	8	-	7	16.67%
Jun 30, 2023	21	10.53%	16,730,361	0.17%	62	1.57%	8	14.29%	6	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	899.65K	1.34%	671.30K
iShares Russell 2000 ETF	723.54K	1.08%	-1.62K
T. Rowe Price Health Sciences	530.30K	0.79%	530.30K
Vanguard Institutional Extnd Mkt Idx Tr	404.12K	0.60%	285.04K
iShares Russell 2000 Value ETF	257.81K	0.38%	-
Fidelity Extended Market Index	152.15K	0.23%	113.52K
Vanguard Russell 2000 ETF	131.94K	0.20%	102.63K
State St Russell Sm Cap® Indx SL Cl I	107.70K	0.16%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	81.11K	0.12%	12.30K
Fidelity Small Cap Index	73.98K	0.11%	-3.58K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 20, 2024	Pimblett Emily	CHIEF ACCOUNTING OFFICER	Sell	$72.54
Sep 20, 2024	Pimblett Emily	CHIEF ACCOUNTING OFFICER	Sell	$9.67K
Jul 19, 2024	Morisset Valerie	EVP, R&D AND CSO	Sell	$362.00K
Jul 22, 2024	Morisset Valerie	EVP, R&D AND CSO	Sell	$314.77K
Jul 19, 2024	Morisset Valerie	EVP, R&D AND CSO	Sell	$72.33K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	16
2024 Q2	2	1
2024 Q1	-	-
2023 Q3	-	-
2023 Q2	-	-

ELYM Ownership FAQ

Who Owns Eliem Therapeutics?

Eliem Therapeutics shareholders are primarily institutional investors at 164.45%, followed by 10.38% insiders and -74.83% retail investors. The average institutional ownership in Eliem Therapeutics's industry, Biotech Stocks , is 45.43%, which Eliem Therapeutics exceeds.

Who owns the most shares of Eliem Therapeutics?

Eliem Therapeutics’s largest shareholders are Ra capital management (31.42M shares, 103.52%), Deep track capital, lp (3.9M shares, 12.87%), and Samsara biocapital (3.26M shares, 10.75%). Together, they hold 127.14% of Eliem Therapeutics’s total shares outstanding.

Does Blackrock own Eliem Therapeutics?

Yes, BlackRock owns 1.38% of Eliem Therapeutics, totaling 381.72K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 2.71M$. In the last quarter, BlackRock increased its holdings by 351.28K shares, a 1154.02% change.

Who is Eliem Therapeutics’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is Eliem Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.85% of its assets in 3.26M Eliem Therapeutics shares, valued at 23.19M$.

Who is the top mutual fund holder of Eliem Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eliem Therapeutics shares, with 1.34% of its total shares outstanding invested in 899.65K Eliem Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools